The Rising Prevalence of Chagas Disease to Drive Growth in the Chagas Disease Treatment Market Chagas disease, also known as American trypanosomiasis, is caused by the protozoan parasite Trypanosoma cruzi. The disease, which is transmitted by the reduviid bug, is endemic in 21 countries in Latin America where around 6 to 7 million people are estimated to be infected. Rising awareness about the disease and screening programs are fueling the Chagas Disease Treatment Market Demand for treatment drugs. Governments in Latin American countries have launched initiatives for screening blood donors and pregnant women to curb the spread of the disease. The COVID-19 pandemic has greatly impacted the Chagas Disease Treatment Market Challenges And Opportunities. Get more insights: Chagas Disease Treatment Market (https://www.newswirestats.com/chagas-disease-treatment-market-analysis/) #CoherentMarketInsights #ChagasDiseaseTreatmentMarket #Benznidazole #Nifurtimoz #Hospitals #RetailPharmacies #OnlinePharmacies